Bay Harbor Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.96K Buy
31
+7
+29% +$1.74K ﹤0.01% 286
2025
Q4
$5.78K Buy
24
+2
+9% +$511 ﹤0.01% 260
2025
Q3
$6.02K Hold
22
﹤0.01% 180
2025
Q2
$5.68K Buy
22
+3
+16% +$716 ﹤0.01% 170
2025
Q1
$4.25K Buy
19
+6
+46% +$1.4K ﹤0.01% 145
2024
Q4
$2.97K Hold
13
﹤0.01% 145
2024
Q3
$3.17K Buy
13
+5
+63% +$1.12K ﹤0.01% 136
2024
Q2
$1.53K Buy
+8
New +$1.62K ﹤0.01% 156
2020
Q1
Sell
-12
Closed -$2K 395
2019
Q4
$2K Hold
12
﹤0.01% 296
2019
Q3
$2K Buy
+12
New +$1.57K ﹤0.01% 310

Other funds holding RMD

Bay Harbor Wealth Management's RMD Position: Q1 2026 in Review

Bay Harbor Wealth Management increased its ResMed (RMD) stake by 29% in Q1 2026, buying an estimated $1.74K and bringing the position to 31 shares worth $6.96K. The position accounts for ﹤0.01% of the portfolio, ranked #286.

Bay Harbor Wealth Management first reported a position in RMD in Q3 2019 and has held it in 10 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Bay Harbor Wealth Management held 31 shares of ResMed worth $6.96K as of Q1 2026.
  • Bay Harbor Wealth Management bought 7 ResMed shares in Q1 2026, an estimated $1.74K.
  • ResMed made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q1 2026, its #286 holding.
  • Bay Harbor Wealth Management first reported a position in ResMed in Q3 2019 and has held it in 10 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q1 2026, filed 14 Apr 2026.